Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.48 |
| ▸ | RPS6KA1 | Q15418 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.35 |
| ▸ | HPGD | P15428 | 2/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | HTR1B | P28222 | 2/20 | 0.33 |
| ▸ | MAOB | P27338 | 2/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | USP2 | O75604 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | PNMT | P11086 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3765885 | 0.92 | KDM4E (0.40) | KDM4ERPS6KA1L3MBTL1MAPTALDH1A1 | |
| SCHEMBL3763009 | 0.91 | KDM4E (0.39) | KDM4ERPS6KA1L3MBTL1MAPTALDH1A1 | |
| SCHEMBL3759944 | 0.89 | KDM4E (0.38) | KDM4ERPS6KA1L3MBTL1MAPTALDH1A1 | |
| SCHEMBL3766502 | 0.89 | KDM4E (0.38) | KDM4ERPS6KA1L3MBTL1MAPTALDH1A1 | |
| SCHEMBL23680099 | 0.85 | KDM4E (0.55) | KDM4EL3MBTL1MAPTALDH1A1HPGD | |
| SCHEMBL3766260 | 0.83 | MAPT (0.49) | KDM4EL3MBTL1MAPTALDH1A1HPGD | |
| SCHEMBL3764835 | 0.81 | RPS6KA1 (0.35) | KDM4ERPS6KA1L3MBTL1MAPTALDH1A1 | |
| SCHEMBL3772715 | 0.80 | RPS6KA1 (0.34) | KDM4ERPS6KA1L3MBTL1MAPTHPGD | |
| SCHEMBL3766158 | 0.80 | CYP1A2 (0.35) | KDM4ERPS6KA1L3MBTL1MAPTHPGD | |
| SCHEMBL17008110 | 0.79 | KDM4E (0.43) | KDM4EL3MBTL1MAPTALDH1A1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100311790-A1 | AMIDE COMPOUNDS AND PLANT DISEASE CONTROLLING METHOD USING SAME | SUMITOMO CHIEMCAL COMPANY LIMITED (JP) | 2010-12-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100311790-A1 | AMIDE COMPOUNDS AND PLANT DISEASE CONTROLLING METHOD USING SAME | ATL3, NAT1, C5 | KDM4E 2021/4885RPS6KA1 1556/4885L3MBTL1 40/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.